James Woodruff Lillie
CIK 1728746 · Chief Scientific Officer · last filed 2026-05-11
James Woodruff Lillie is a Chief Scientific Officer who has filed 8 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider sold $20.4K of MPLT on May 11, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.74M
3
8
-$1.61M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MPLT | Chief Scientific Officer | 242,729 | $27.75 | $6.74M | -$1.61M | 6 | 2026-05-11 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Chief Scientific Officer | — | $15.90 | — | $0 | 1 | 2018-12-11 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Chief Scientific Officer | — | — | — | $0 | 1 | 2018-03-06 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | MPLT | Sell (S) | −721 | -$20.4K | EDGAR |
| 2026-05-06 | MPLT | Sell (S) | −51,707 | -$1.47M | EDGAR |
| 2026-04-17 | MPLT | Sell (S) | −4,513 | -$122.6K | EDGAR |
| 2026-02-09 | MPLT | Grant (A) | +7,730 | $0 | EDGAR |
| 2026-01-29 | MPLT | Tax (F) | −45,055 | -$810.1K | EDGAR |
| 2025-10-28 | MPLT | Grant (A) | +32,539 | $0 | EDGAR |
| 2018-12-11 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-06 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |